Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-18 4:18 pm Sale | 13D | STOKE THERAPEUTICS INC STOK | Skorpios Trust | 10,843,681 23.4% | -3,600,000 (-24.92%) | View |
| 2024-02-26 10:38 am Purchase | 13G | STOKE THERAPEUTICS INC STOK | Cowen Financial Products LLC | 3,721,659 8.3% | 1,445,553 (+63.51%) | View |
| 2024-02-26 10:36 am Purchase | 13G | STOKE THERAPEUTICS INC STOK | Cowen Financial Products LLC | 2,276,106 5.77% | 1,028,029 (+82.37%) | View |
| 2024-02-14 4:26 pm Sale | 13G | STOKE THERAPEUTICS INC STOK | Redmile Group LLC | 2,625,506 5.9% | -1,541,469 (-36.99%) | View |
| 2024-02-14 09:20 am Purchase | 13G | STOKE THERAPEUTICS INC STOK | Lynx1 Capital Management LP | 2,956,918 6.6% | 292,760 (+10.99%) | View |
| 2024-02-14 07:44 am Purchase | 13G | STOKE THERAPEUTICS INC STOK | RTW INVESTMENTS LP | 4,131,045 9.3% | 260,064 (+6.72%) | View |
| 2024-02-09 2:51 pm Purchase | 13G | STOKE THERAPEUTICS INC STOK | MORGAN STANLEY MS | 3,358,375 7.5% | 910,161 (+37.18%) | View |
| 2024-02-09 09:49 am Sale | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 5,000 0.011% | -3,029,649 (-99.84%) | View |
| 2023-11-06 4:55 pm Purchase | 13G | STOKE THERAPEUTICS INC STOK | Lynx1 Capital Management LP | 2,664,158 6% | 2,664,158 (New Position) | View |
| 2023-02-14 10:08 am Purchase | 13G | STOKE THERAPEUTICS INC STOK | RTW INVESTMENTS LP | 3,870,981 9.8% | 226,733 (+6.22%) | View |
| 2023-02-10 11:50 am Purchase | 13G | STOKE THERAPEUTICS INC STOK | MORGAN STANLEY MS | 2,448,214 6.2% | 2,448,214 (New Position) | View |
| 2023-02-09 12:31 pm Purchase | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 3,034,649 7.696% | 479,850 (+18.78%) | View |
| 2023-02-09 11:32 am Sale | 13G | STOKE THERAPEUTICS INC STOK | VANGUARD GROUP INC | 1,602,045 4.06% | -310,137 (-16.22%) | View |
| 2023-02-03 5:16 pm Purchase | 13G | STOKE THERAPEUTICS INC STOK | Redmile Group LLC | 4,166,975 9.7% | 1,920,307 (+85.47%) | View |
| 2023-01-25 3:45 pm Sale | 13G | STOKE THERAPEUTICS INC STOK | Cowen Financial Products LLC | 1,248,077 1.89% | -623,452 (-33.31%) | View |
| 2022-02-14 5:07 pm Sale | 13G | STOKE THERAPEUTICS INC STOK | Redmile Group LLC | 2,246,668 6.1% | -439,566 (-16.36%) | View |
| 2022-02-14 08:07 am Purchase | 13G | STOKE THERAPEUTICS INC STOK | RTW INVESTMENTS LP | 3,644,248 9.9% | 100,000 (+2.82%) | View |
| 2022-02-10 08:37 am Purchase | 13G | STOKE THERAPEUTICS INC STOK | VANGUARD GROUP INC | 1,912,182 5.2% | 1,912,182 (New Position) | View |
| 2022-02-09 10:01 am Sale | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 2,554,799 6.944% | -1,046,176 (-29.05%) | View |
| 2022-01-24 07:44 am Purchase | 13G | STOKE THERAPEUTICS INC STOK | Cowen Financial Products LLC | 1,871,529 5.09% | 1,871,529 (New Position) | View |